Tiotropium Respimat？ 2.5 μg Add-on to ICS or ICS+controller medications Improves Lung Function in Adults and Adolescents With Mild, Moderate, or Severe Symptomatic Asthma

DOI: 10.1016/j.jaci.2016.12.312

Full-Text   Cite this paper   Add to My Lib

Abstract:

To investigate lung function in adults and adolescents (12–17 years old) taking tiotropium Respimat？(TioR) 2.5 μg plus ICS or ICS+controller medications.

Full-Text